Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 75, Issue 7
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs - March 01, 2017
PDF
PDF +
Supplementary
Material
Clinical and epidemiological research
Extended report
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs
Online download statistics by month:
Online download statistics by month: August 2015 to March 2024
Abstract
Full
Pdf
Aug 2015
897
398
526
Sep 2015
343
273
291
Oct 2015
104
118
106
Nov 2015
90
139
96
Dec 2015
97
116
90
Jan 2016
1060
211
273
Feb 2016
156
113
89
Mar 2016
105
110
109
Apr 2016
81
118
105
May 2016
77
105
85
Jun 2016
1572
224
326
Jul 2016
656
164
198
Aug 2016
336
82
75
Sep 2016
275
120
83
Oct 2016
195
152
117
Nov 2016
125
102
62
Dec 2016
133
166
64
Jan 2017
130
162
71
Feb 2017
11
122
84
Mar 2017
10
127
100
Apr 2017
8
169
48
May 2017
5
123
50
Jun 2017
59
171
39
Jul 2017
142
138
44
Aug 2017
131
119
62
Sep 2017
153
132
47
Oct 2017
185
176
56
Nov 2017
244
232
53
Dec 2017
301
295
30
Jan 2018
304
292
59
Feb 2018
203
169
48
Mar 2018
231
223
47
Apr 2018
218
212
39
May 2018
226
219
56
Jun 2018
185
170
39
Jul 2018
140
136
43
Aug 2018
186
179
57
Sep 2018
163
155
41
Oct 2018
177
177
40
Nov 2018
180
171
36
Dec 2018
123
113
28
Jan 2019
132
122
41
Feb 2019
168
161
56
Mar 2019
149
143
49
Apr 2019
81
73
28
May 2019
113
105
43
Jun 2019
108
101
40
Jul 2019
93
79
41
Aug 2019
119
100
42
Sep 2019
85
72
37
Oct 2019
105
97
44
Nov 2019
85
79
48
Dec 2019
105
99
53
Jan 2020
117
103
56
Feb 2020
141
120
51
Mar 2020
76
68
36
Apr 2020
62
62
108
May 2020
50
50
54
Jun 2020
46
36
39
Jul 2020
59
52
46
Aug 2020
51
41
32
Sep 2020
59
49
34
Oct 2020
81
68
39
Nov 2020
58
53
44
Dec 2020
84
70
39
Jan 2021
73
62
45
Feb 2021
64
50
46
Mar 2021
59
51
48
Apr 2021
48
38
37
May 2021
59
54
28
Jun 2021
38
38
36
Jul 2021
53
52
60
Aug 2021
42
40
43
Sep 2021
48
48
49
Oct 2021
67
61
46
Nov 2021
51
46
56
Dec 2021
46
40
36
Jan 2022
44
43
29
Feb 2022
87
74
36
Mar 2022
63
57
39
Apr 2022
89
78
44
May 2022
73
69
46
Jun 2022
68
62
28
Jul 2022
54
41
28
Aug 2022
73
57
26
Sep 2022
69
60
96
Oct 2022
55
40
18
Nov 2022
62
49
45
Dec 2022
44
31
20
Jan 2023
85
57
20
Feb 2023
77
63
24
Mar 2023
61
53
23
Apr 2023
41
37
29
May 2023
42
36
30
Jun 2023
35
26
22
Jul 2023
53
44
30
Aug 2023
87
62
31
Sep 2023
36
30
18
Oct 2023
52
50
12
Nov 2023
57
49
25
Dec 2023
59
58
20
Jan 2024
37
37
19
Feb 2024
52
37
16
Mar 2024
45
39
16
Total
14492
10815
6332
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF